Document is current

Any future updates will be listed below

Development and Optimization of Olaparib-Encapsulated Silica Nanocarriers for Enhanced Therapeutic Efficacy in Ovarian Cancer: Cytotoxicity Profiling in HaCaT and SK-OV-3 Cell Models

Crossref DOI link: https://doi.org/10.1007/s12247-025-10324-w

Published Online: 2026-01-06

Published Print: 2026-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark